@OncoResponse

We're leveraging the human immune system to fight cancer. Interrogating for Cures™ #EliteCancerResponders

 Seattle, WA
oncoresponse.com
Joined August 2021
  • Tweets81
  • Following43
  • Followers38
55Media
OncoResponse, a clinical-stage biotech company advancing immunotherapies derived from the immune systems of Elite Cancer Responders, today announced it has raised $14M in funding. bit.ly/3BCYn3z #OncoResponse #biotechnology #chatgptai #medtechproblems
2
3
94
#grants, awards ~@PulvinarNeuro awarded $3M @NIH #Grant for #TranscranialStimulation research ~@OncoResponse awarded $13M #funding from @CPRITTexas + $14M from #investors ~@NIH awards $14.4M to @NDRI_Resource in collab with @UMmedschool, @AllChildrens
Image Source: NIH Common Fund

ALT Image Source: NIH Common Fund

1
2
91
OncoResponse retweeted
Canaan@canaanpartners18 May 2023
Replying to @OncoResponse
@OncoResponse adds $27M to support advancement of novel #immunotherapy programs. Funds come from CPRIT grant, as well as existing investor syndicate. OR2805 in Phase 1 trial; OR502 moving to IND and clinic. Canaan’s @WendeHutton is on co's board. oncoresponse.com/news-center…
1
1
60
And we're off! Kamal Puri of @OncoResponse representing with the official Climb to Fight Cancer baselayer. @fredhutch #ClimbToFight #ClimbForCancer
1
6
226
The Kilimanjaro team has raised $600K for cancer research, on pace to hit $1M goal. Thanks to Trek sponsors @elevatebio @goodwinlaw @OncoResponse and Base Camp sponsors @canaanpartners @LinusGroup and We Can Rise, a group advancing women in leadership. fredhutch.org/en/events/clim…
4
1
5
Bob Lechleider of @OncoResponse discusses the tumor microenvironment, how his company is studying elite responders to immunotherapies to discover new antibodies to modulate the immune system, and his company’s lead program in clinical development. soundcloud.com/levine-media-…
2
2
OncoResponse retweeted
BioSpace@biospace10 May 2022
Replying to @OncoResponse
@OncoResponse is developing an innovative cancer therapy based upon antibodies produced by patients to components in the tumor microenvironment that regulate the immune response. #OncoResponse #CancerTherapy #BioSpace hubs.li/Q019Xmd70
1
1
2
We advised @OncoResponse, a clinical-stage biotech company advancing immunotherapies for the treatment of cancer patients, in the closing of a US$50 million senior secured term loan. Learn more about this transaction: ow.ly/quY350I0yvm @HLLifeSciences #CancerTreatment
A close-up of a laboratory technician in full personal protective gear performing a test on a pink substance in a petri dish, with text: “Our Work – OncoResponse’s closing of US$50m senior secured loan”

ALT A close-up of a laboratory technician in full personal protective gear performing a test on a pink substance in a petri dish, with text: “Our Work – OncoResponse’s closing of US$50m senior secured loan”

1
1
2
Come join our salon discussion on Wednesday. A little JPM prep talk.
1
2
R&D team had a very successful showing at SITC. Three well attended poster presentations including our clinical stage macrophage specific antibody #OR2805 #EndCancer
OncoResponse@OncoResponse12 Nov 2021
#OncoResponse Presents Data on Multiple Immuno-oncology Agents at the Society for Immunotherapy of Cancer's 36th Annual Meeting (#SITC21) oncoresponseinc.com/news-cen… @sitcancer
1
1
Replying to @OncoResponse
Exciting times at OncoResponse as we enter clinical trials. Very happy to be studying OR2805 in cancer patients.
2
1
Load more